CIPLA
|
The Current P/S Ratio of CIPLA is 4.48.
Share Price | ₹1,541.4 | Sep 08,2025 |
Market Cap | ₹124,514.3 Cr | |
Sales-TTM | ₹27,811.2 Cr | TTM-Consolidated Results |
Price/Sales | 4.48x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of CIPLA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹124,514.3 Cr] as on Sep 08,2025
(/) Sales [ ₹27,811.2 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 4.48x ]
Thus, for CIPLA , the investors are currently willing to pay '4.48 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of CIPLA !
The chart below summarizes the trend in P/S Ratio of CIPLA over the last five years.
Historical PS (Price/Sales) ratio chart of CIPLA
PS Ratio Performance Analysis for CIPLA
- CIPLA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 3.86x.
- CIPLA 's operated at median p/e ratio of 3.78x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, CIPLA 's p/e ratio peaked in Mar2024 at 4.68x.
- CIPLA 's p/e ratio hit its five-year low in Mar2023 of 3.19x.
How does CIPLA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
CIPLA | 27,811.2 | 4.48 | 124,514.3 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 53,777.1 | 7.05 | 379,191.0 |
DIVIS LABORATORIES LTD | 9,652.0 | 16.57 | 159,973.0 |
TORRENT PHARMACEUTICALS LTD | 11,835.0 | 10.32 | 122,175.0 |
DR REDDYS LABORATORIES LTD | 33,519.9 | 3.11 | 104,355.0 |
MANKIND PHARMA LTD | 12,956.2 | 8.21 | 106,434.0 |
ZYDUS LIFESCIENCES LTD | 23,607.7 | 4.30 | 101,544.0 |
LUPIN LTD | 23,375.9 | 3.80 | 88,934.7 |
AUROBINDO PHARMA LTD | 32,024.8 | 1.89 | 60,417.9 |
ABBOTT INDIA LTD | 6,589.9 | 9.99 | 65,829.7 |
ALKEM LABORATORIES LTD | 13,303.8 | 4.78 | 63,609.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs CIPLA 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 1.89x |
Max industry PS | 16.57x |
Median industry PS | 4.78x |
Average industry PS | 6.77x |
You may also like the below Video Courses